While not commonly considered a leading cause of death, sudden cardiac death is a health issue that continues to cause premature deaths every year. In fact, sudden cardiac death is estimated to occur over 5 million times around the world every year, and 200,000 of those cases are in the United States alone.
Because of this, it is imperative the main causes of such events are identified and used to effectively prevent and and lower the general public’s risk of sudden cardiac death. In an effort to help mitigate such risks, Grune et al published a study using an Azure Sapphire to further the scientific community’s knowledge on the subject using both mouse and human models by investigating the relationship between leukocytes and ventricular arrhythmia.
Research Applications with the Sapphire Biomolecular Imager
Grune et al primarily employed the Azure Sapphire Biomolecular Imager to collect fluorescent images of tissue sections from mouse hearts. The Sapphire is the ideal tool for enhanced quantitative imaging thanks to its stable fluorescent signals, which help achieve reliable quantitation across a wide dynamic range. The Sapphire’s multiplexing ability allows probing for multiple proteins on a single blot, expanding the amount of data that can be collected from each sample.
Leukocytes and Their Role Surrounding Sudden Cardiac Death
The authors sought to identify correlations between leukocytes and ventricular arrhythmia and to also study how hypokalemia (low potassium levels) combined with myocardial infarction may trigger spontaneous ventricular tachycardia.
They established neutrophils incited ventricular arrhythmia in mice and determined a higher circulating neutrophil count was associated with a higher risk of early Vfib and VTand an adverse prognosisin patients with MI.
Using their mouse models, the authors determined a lack of macrophages (which remove dead cells) can impair efferocytosis and lead to a faster death rate in cardiomyocytes (muscles cells that are responsible for making the heart contract).
Post-MI was injected into the mice with an imaging probe that binds to the surface of apoptotic cells and the interior of necrotic cells. The mouse hearts were then processed and imaged with fluorescent reflectance imaging (FRI) on the Sapphire. The imaging probe primarily bound to infarcts and the researchers concluded that absence of macrophages can result in a increased death rate of cardiomyocytes and potential accumulation of these dead cells in mice.
Next, the authors investigated the role Mertk, a macrophage receptor that helps mediate efferocytosis and assists with mitochondrial removal from malfunctioning cardiomyocytes. The authors hypothesized that Mertk may help protect against post-MI ventricular arrhythmias like VT and Vfib., as deletion of Mertk receptors leads to lethal arrhythmias in mice with acute MI. Through several small experiments, they concluded that their hypothesis was correct.
Because of these results, the study concludes that macrophages, a type of leukocyte, are indeed effective at averting electrical storms after MI. In addition, macrophages play a large role in defending against post-MI arrhythmias such as VT and Vfib. Lastly, the study’s results demonstrate that unlike macrophages, neutrophils actually increase VT in mice and are closely associated with VT in patients.
This study importantly demonstrates that changes to the function of leukocytes like neutrophils and macrophages may prove to be useful therapeutic tools for reducing the likelihood of sudden cardiac death. A better understanding of these functions may eventually lead to effective anti-arrhythmic drugs.
Background on Heart Function and Health Conditions
The myocardium is the muscular layer of the heart that is negatively charged on one side and positively charged on the other. Disruption of the normal rhythmic depolarization of the myocardium can lead to sudden cardiac death. One of the most common causes of sudden cardiac death is thought to be arrhythmias, or abnormal heart rhythms. When arrhythmias occur, the heart is unable to pump blood, which can subsequently lead to heart failure and ultimately death.
There are two types of arrhythmias: ventricular tachycardia (VT) and ventricular fibrillation (Vfib). They are considered to be some of the most common causes of sudden cardiac death. As such, preventing VT and Vfib may be an effective means of addressing this health concern. Historically, leukocytes have been considered an effective tool in preventing arrhythmias, but they may also contribute to rhythm disorders. In fact, some studies show that health conditions associated with an increased risk of arrhythmia are often also associated with major changes in myocardial leukocyte counts.
Macrophages and neutrophils are types of leukocytes that engulf and digest particles (including pathogens and dead cells) to defend the human body. The process of removing these particles is called efferocytosis. Macrophages are especially responsible for clearing away dead cells; if they do not, the accumulation of cellular debris may indirectly lead to VT. In this study, macrophages are particularly important because they remove dead cardiomyocytes, the muscles cells responsible for making the heart contract, which in turn can help a patient heal after ischemia.
Used in This Study: Azure Sapphire Biomolecular Imager
The Sapphire is capable of imaging whole specimens, like Arabidopsis thaliana plants, zebrafish, whole mice, and fruit fly, mouse, and frog embryos. For studies on gels or well plates, the Sapphire Biomolecular Imager can be used for in-cell Westerns, chemiluminescence, gel documentation, total protein normalization, bacterial plate imaging, phosphor imaging, and investigating post-translational modifications.
To learn more about the Sapphire Biomolecular Imager used in this study and how it can be an effective tool in your own research, contact us at email@example.com.
More research done with the Azure Sapphire:
Grune, J. et al (2022). Neutrophils incite and macrophages avert electrical storm after myocardial infarction. Nature Cardiovascular Research, 1(7), 649–664. https://doi.org/10.1038/s44161-022-00094-w